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Background:  Though studies have reported an increased cardiovascular risk with most non-steroidal anti-inflammatory drugs (NSAIDs), little is 
known about the risk profile over time following a myocardial infarction (MI). We analyzed the risk of death associated with NSAIDs in relation to the 
time elapsed after MI.
Methods:  Patients aged 30 years or older admitted with first-time MI 1997-2006 and subsequent NSAID use were identified by individual-level 
linkage of nationwide registries of hospitalization and drug dispensing from pharmacies in Denmark. Risk of death related to NSAID use up to 5 
years after MI was analyzed by adjusted multivariable Cox proportional-hazard models. Incidence rates of death per 10,000 person-years were 
calculated for individual NSAIDs.
Results:  Of 83,675 patients included,35,405(42%) received NSAIDs. There were 29,234 deaths (35%) during the observation period.There was a 
persistently increased risk of death over time associated with use of NSAIDs (Figure). Results from the Cox regression analysis showed an increased 
relative risk of death over time in patients receiving any individual NSAID (not shown), in particular for diclofenac (hazard ratio [HR] 1.8; 95% 
confidence interval [CI] 1.5 -2.1 after 1 year and HR 3.5; CI 2.7-4.6 after 5 years) and rofecoxib (HR 1.2; CI 0.8-1.6 after 1 year and HR 2.0; CI 
1.4-2.9 after 5 years).
Conclusion: NSAIDs are associated with persistent increase in risk of death after MI. Long-term caution with use of NSAIDs is advised after MI. 
